There is promising evidence for the use of percentage expression of CD25 and Ki67 cellular markers in providing prognostic information in canine B-cell lymphoma and these should be assessed further in clinical practice. The gene discussed is MKI67; the disease is B-cell non-Hodgkin lymphoma.